Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Certolizumab pegol and its role in pregnancy-age hidradenitis suppurativa.
Repetto F, Burzi L, Ramondetta A, Rozzo G, Licciardello M, Ribero S, Quaglino P, Dapavo P. Repetto F, et al. Among authors: dapavo p. Int J Dermatol. 2022 May;61(5):e182-e184. doi: 10.1111/ijd.15742. Epub 2021 Jul 16. Int J Dermatol. 2022. PMID: 34270087 No abstract available.
Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study.
Torres T, Balato A, Conrad C, Conti A, Dapavo P, Ferreira P, Gaiani F, Leite L, Malagoli P, Mendes-Bastos P, Megna M, Messina F, Nidegger A, Odorici G, Piaserico S, Prignano F, Ribero S, Ricceri F, Tonini A, Valério J, Chiricozzi A. Torres T, et al. Among authors: dapavo p. J Am Acad Dermatol. 2019 Jul;81(1):273-275. doi: 10.1016/j.jaad.2019.02.031. Epub 2019 Feb 18. J Am Acad Dermatol. 2019. PMID: 30790602 No abstract available.
Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study.
Chiricozzi A, Balato A, Conrad C, Conti A, Dapavo P, Ferreira P, Gaiani FM, Leite L, Malagoli P, Mendes-Bastos P, Megna M, Messina F, Nidegger A, Odorici G, Panduri S, Piaserico S, Piscitelli L, Prignano F, Ribero S, Valerio J, Torres T. Chiricozzi A, et al. Among authors: dapavo p. J Dermatolog Treat. 2020 Aug;31(5):476-483. doi: 10.1080/09546634.2019.1671577. Epub 2019 Oct 2. J Dermatolog Treat. 2020. PMID: 31557063 Clinical Trial.
Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in adult cohort: a real-life Italian tertiary centre experience.
Ribero S, Giura MT, Viola R, Ramondetta A, Siliquini N, Cardone P, Tonella L, Quaglino P, Dapavo P, Panzone M, Ortoncelli M, Fierro MT. Ribero S, et al. Among authors: dapavo p. J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e380-e383. doi: 10.1111/jdv.16219. Epub 2020 May 22. J Eur Acad Dermatol Venereol. 2020. PMID: 31960496 No abstract available.
Evidence for a 'window of opportunity' in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort study.
Marzano AV, Genovese G, Casazza G, Moltrasio C, Dapavo P, Micali G, Sirna R, Gisondi P, Patrizi A, Dini V, Bianchini D, Bianchi L, Fania L, Prignano F, Offidani A, Atzori L, Bettoli V, Cannavò SP, Venturini M, Bongiorno MR, Costanzo A, Fabbrocini G, Peris K. Marzano AV, et al. Among authors: dapavo p. Br J Dermatol. 2021 Jan;184(1):133-140. doi: 10.1111/bjd.18983. Epub 2020 Apr 13. Br J Dermatol. 2021. PMID: 32119111 Free article.
Creation of a severity index for hidradenitis suppurativa that includes a validated quality-of-life measure: the HIDRAscore.
Marzano AV, Chiricozzi A, Giovanardi G, Argenziano G, Bettoli V, Bianchi L, Dapavo P, Dini V, Fabbrocini G, Micali G, Offidani AM, Potenza C, Prignano F, Gualberti G, Saragaglia V, Rongioletti F. Marzano AV, et al. Among authors: dapavo p. J Eur Acad Dermatol Venereol. 2020 Aug;34(8):1815-1821. doi: 10.1111/jdv.16328. Epub 2020 May 12. J Eur Acad Dermatol Venereol. 2020. PMID: 32119143 Free PMC article.
136 results